Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ObsEva SA
ObsEva Announces Delisting from SIX Swiss Exchange and Exemption from Certain Obligations Associated with the Maintenance of Listin
April 03, 2024
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Update on Board of Directors
March 19, 2024
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Wind-Down of Operations and Notifies SIX that it Will Lack the Resources to Establish Audited IFRS Financial Statements for 2023
February 28, 2024
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
Geneva Court Grants Temporary Moratorium to ObsEva
January 31, 2024
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals
November 30, 2023
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
Organon Returns Ebopiprant to XOMA
October 27, 2023
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Files half Year 2023 Financial Statements
September 27, 2023
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Recovers Full Worldwide Rights on Nolasiban
July 13, 2023
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
Annual General Meeting 2023
June 08, 2023
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer
May 02, 2023
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Change of Central Securities Depositary
April 20, 2023
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Files Year End 2022 Financial Statements
March 31, 2023
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023
March 15, 2023
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland
March 13, 2023
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland
February 24, 2023
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Dismissal of Moratorium Proceedings
December 19, 2022
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Evidences Compliance with Nasdaq’s Stockholder’s Equity Rule and Announces Moratorium Dismissal Request Filing
December 14, 2022
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva To Increase Issued Share Capital by Creating Additional Treasury Shares
December 09, 2022
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Third Quarter 2022 Financial Results and Provides a Business Update
December 01, 2022
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million
November 22, 2022
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings
October 26, 2022
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces IND Approval for Yuyuan Bioscience’s Phase 1 Clinical Trial of Nolasiban in China
October 13, 2022
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
ObsEva Announces Corporate Updates
July 27, 2022
From
ObsEva SA
Via
GlobeNewswire
Tickers
OBSV
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.